Key result
Pegylated interferon and ribavirin treatment in HCV patients suppressed the transcription of ribosomal proteins and eukaryotic translation factors by approximately 50% in peripheral blood mononuclear cells.
Why the study?
Does Peg-interferon alpha/ribavirin alter gene expression pathways in PBMC of patients infected with HCV?
Observational (n=68)
Does Peg-interferon alpha/ribavirin alter gene expression pathways in PBMC of patients infected with HCV?
Peg-interferon alpha/ribavirin treatment in HCV patients suppresses ribosomal protein synthesis and translation factors, which may explain its long-term side effects and non-specific antiviral effects.
Answers are grounded in this paper and cite their sources.
May explain long-term side effects via ribosomal suppression; hypothesis-generating for non-specific antiviral mechanisms in HCV.
BACKGROUND: We have previously reported the induction of many interferon stimulated genes (ISGs) in PBMC collected from patients infected with HCV at various times after initiation of interferon-ribavirin treatment using DNA microarrays to identify changes in gene expression with time. Almost as many genes are down regulated (suppressed) during interferon-ribavirin treatment as are up regulated. METHODS: DNA microarrays were analyzed by different software, including MAS5 (Affymetrix-Kegg) and GSEA (gene set enrichment analysis) to identify specific pathways both up regulated and down regulated. Data was assessed from a clinical trial, which was a microarray analysis from 68 patients. RESULTS: Up regulated genes included genes associated with NF-kb, toll like receptor cytokine -cytokine interaction, and complement and adhesion pathways. The most prominent pathway down regulated was that for ribosomal structural proteins, and eukaryotic translational factors. Down regulation of ribosomal protein genes continued through the treatment up to the last measurement, which was at day 28. CONCLUSIONS: This suppression of the protein synthetic apparatus might explain the long-term side effects of interferon-ribavirin, and explain a non-specific effect of interferon-ribavirin on viral protein synthesis. There was no evidence for unique transcription factors or micro RNA involvement.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2012) conducted an observational in Hepatitis C (n=68). Peg-interferon alpha/ribavirin vs. Before treatment (baseline) was evaluated on Changes in gene expression pathways (up-regulation and down-regulation) in peripheral blood mononuclear cells. Pegylated interferon and ribavirin treatment in HCV patients suppressed the transcription of ribosomal proteins and eukaryotic translation factors by approximately 50% in peripheral blood mononuclear cells.
Synapse has enriched 10 related papers. Consider them for comparative context: